Variation in the immune responses against Plasmodium falciparum merozoite surface protein-1 and apical membrane antigen-1 in children residing in the different epidemiological strata of malaria in Cameroon
暂无分享,去创建一个
[1] K. Tufon,et al. Comparative evaluation of a rapid diagnostic test, an antibody ELISA, and a pLDH ELISA in detecting asymptomatic malaria parasitaemia in blood donors in Buea, Cameroon , 2017, Infectious Diseases of Poverty.
[2] A. Latz,et al. Epidemiological and clinical profile of paediatric malaria: a cross sectional study performed on febrile children in five epidemiological strata of malaria in Cameroon , 2017, BMC Infectious Diseases.
[3] A. Latz,et al. Identification of the Plasmodium species in clinical samples from children residing in five epidemiological strata of malaria in Cameroon , 2017, Tropical Medicine and Health.
[4] A. Njunda,et al. The prevalence of malaria in people living with HIV in Yaounde, Cameroon , 2016, BMC Public Health.
[5] Tayong D B Kwenti,et al. The Effect of Intestinal Parasitic Infection on the Clinical Outcome of Malaria in Coinfected Children in Cameroon , 2016, PLoS neglected tropical diseases.
[6] I. Mutingwende,et al. Evaluation of specific antibody responses to selected malaria vaccine candidates in Zimbabwean children , 2015 .
[7] Michelle L. Gatton,et al. Microscopy for the detection, identification and quantification of malaria parasites on stained thick and thin blood films in research settings , 2015 .
[8] A. N. Nloga,et al. Study of entomological parameters involved in the transmission of Plasmodium parasite in Anopheles gambiae in the city of Maroua, Far North Region Cameroon. , 2014 .
[9] T. Nkuo-Akenji,et al. Variation in malariometric and red cell indices in children in the Mount Cameroon area following enhanced malaria control measures: evidence from a repeated cross-sectional study , 2014, Malaria Journal.
[10] Aparup Das,et al. Molecular Evidence of Plasmodium vivax Mono and Mixed Malaria Parasite Infections in Duffy-Negative Native Cameroonians , 2014, PloS one.
[11] Huguette Gaelle Ngassa Mbenda,et al. Does malaria epidemiology project Cameroon as ‘Africa in miniature’? , 2014, Journal of Biosciences.
[12] K. Haldar,et al. Molecular typing reveals substantial Plasmodium vivax infection in asymptomatic adults in a rural area of Cameroon , 2014, Malaria Journal.
[13] J. Assob,et al. Comparison of capillary and venous blood using blood film microscopy in the detection of malaria parasites: A hospital based study , 2013 .
[14] C. Antonio-Nkondjio,et al. Impact of cyfluthrin (Solfac EW050) impregnated bed nets on malaria transmission in the city of Mbandjock : lessons for the nationwide distribution of long-lasting insecticidal nets (LLINs) in Cameroon , 2013, Parasites & Vectors.
[15] E. Achidi,et al. Severe and uncomplicated falciparum malaria in children from three regions and three ethnic groups in Cameroon: prospective study , 2012, Malaria Journal.
[16] V. Wiseman,et al. Malaria prevalence and treatment of febrile patients at health facilities and medicine retailers in Cameroon , 2011, Tropical medicine & international health : TM & IH.
[17] A. Hubbard,et al. Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. , 2011, The Journal of infectious diseases.
[18] A. Oduro,et al. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana , 2011, Malaria Journal.
[19] O. Ramilo,et al. Challenges in infant immunity: implications for responses to infection and vaccines , 2011, Nature Immunology.
[20] S. Self,et al. Ontogeny of Toll-Like Receptor Mediated Cytokine Responses of Human Blood Mononuclear Cells , 2010, PloS one.
[21] Jack S. Richards,et al. The Relationship between Anti-merozoite Antibodies and Incidence of Plasmodium falciparum Malaria: A Systematic Review and Meta-analysis , 2010, PLoS medicine.
[22] O. Gaye,et al. The Quantity and Quality of African Children's IgG Responses to Merozoite Surface Antigens Reflect Protection against Plasmodium falciparum Malaria , 2009, PloS one.
[23] K. Marsh,et al. Analysis of Immunity to Febrile Malaria in Children That Distinguishes Immunity from Lack of Exposure , 2009, Infection and Immunity.
[24] E. Seto,et al. Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda. , 2008, The Journal of infectious diseases.
[25] R. Chilengi,et al. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children , 2008, Malaria Journal.
[26] D. Conway,et al. Breadth and Magnitude of Antibody Responses to Multiple Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Clinical Malaria , 2008, Infection and Immunity.
[27] A. Thomas,et al. Apical membrane antigen 1: a malaria vaccine candidate in review. , 2008, Trends in parasitology.
[28] S. Cousens,et al. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria? , 2008, Tropical medicine & international health : TM & IH.
[29] Shona Wilson,et al. Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection , 2007, BMC infectious diseases.
[30] D. Conway,et al. IgG antibody responses to Plasmodium falciparum merozoite antigens in Kenyan children have a short half-life , 2007, Malaria Journal.
[31] C. Long,et al. Fetal Immune Responses to Plasmodium falciparum Antigens in a Malaria-Endemic Region of Cameroon1 , 2007, The Journal of Immunology.
[32] G. Soula,et al. Molecular epidemiology of malaria in Cameroon. XXI. Baseline therapeutic efficacy of chloroquine, amodiaquine, and sulfadoxine-pyrimethamine monotherapies in children before national drug policy change. , 2006, The American journal of tropical medicine and hygiene.
[33] T. Williams,et al. Human red blood cell polymorphisms and malaria. , 2006, Current opinion in microbiology.
[34] A. Cowman,et al. Invasion of Red Blood Cells by Malaria Parasites , 2006, Cell.
[35] K. Marsh,et al. Clinical features and pathogenesis of severe malaria. , 2004, Trends in parasitology.
[36] A. Holder,et al. The Fine Specificity, but Not the Invasion Inhibitory Activity, of 19-Kilodalton Merozoite Surface Protein 1-Specific Antibodies Is Associated with Resistance to Malarial Parasitemia in a Cross-Sectional Survey in The Gambia , 2004, Infection and Immunity.
[37] Virander S. Chauhan,et al. Comparison of Immunogenicities of Recombinant Plasmodium vivax Merozoite Surface Protein 1 19- and 42-Kilodalton Fragments Expressed in Escherichia coli , 2004, Infection and Immunity.
[38] Markus S. Mueller,et al. A Role for Apical Membrane Antigen 1 during Invasion of Hepatocytes by Plasmodium falciparum Sporozoites* , 2004, Journal of Biological Chemistry.
[39] A. Holder,et al. Fine Specificity of Serum Antibodies to Plasmodium falciparum Merozoite Surface Protein, PfMSP-119, Predicts Protection from Malaria Infection and High-Density Parasitemia , 2004, Infection and Immunity.
[40] O. Branch,et al. Antibodies That Inhibit Binding of Plasmodium falciparum-Infected Erythrocytes to Chondroitin Sulfate A and to the C Terminus of Merozoite Surface Protein 1 Correlate with Reduced Placental Malaria in Cameroonian Women , 2004, Infection and Immunity.
[41] R. Sauerwein,et al. Transmission of Plasmodium falciparum in urban Yaoundé, Cameroon, is seasonal and age-dependent. , 2003, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[42] Caroline Ajonina,et al. Anopheles species of the mount Cameroon region: biting habits, feeding behaviour and entomological inoculation rates , 2003, Tropical medicine & international health : TM & IH.
[43] A. Saul,et al. In Vitro Studies with Recombinant Plasmodium falciparum Apical Membrane Antigen 1 (AMA1): Production and Activity of an AMA1 Vaccine and Generation of a Multiallelic Response , 2002, Infection and Immunity.
[44] V. Titanji,et al. The epidemiology of Plasmodium falciparum malaria in two Cameroonian villages: Simbok and Etoa. , 2000, The American journal of tropical medicine and hygiene.
[45] T. Triglia,et al. Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species , 2000, Molecular Microbiology.
[46] D. Conway,et al. Analysis of Human Antibodies to Erythrocyte Binding Antigen 175 of Plasmodium falciparum , 2000, Infection and Immunity.
[47] C. Rogier,et al. Cytophilic Immunoglobulin Responses to Plasmodium falciparum Glutamate-Rich Protein Are Correlated with Protection against Clinical Malaria in Dielmo, Senegal , 2000, Infection and Immunity.
[48] T. Theander,et al. A Longitudinal Study of Human Antibody Responses toPlasmodium falciparum Rhoptry-Associated Protein 1 in a Region of Seasonal and Unstable Malaria Transmission , 1999, Infection and Immunity.
[49] R. Snow,et al. A climate-based distribution model of malaria transmission in sub-Saharan Africa. , 1999, Parasitology today.
[50] A. Holder,et al. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. , 1998, Journal of immunology.
[51] A. Thomas,et al. The Glutamate-Rich Protein (GLURP) of Plasmodium falciparum Is a Target for Antibody-Dependent Monocyte-Mediated Inhibition of Parasite Growth In Vitro , 1998, Infection and Immunity.
[52] A. Holder,et al. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum , 1995, Infection and immunity.
[53] T. Waldmann,et al. Metabolic properties of IgG subclasses in man. , 1970, The Journal of clinical investigation.
[54] W H TALIAFERRO,et al. Acquired immunity in malaria. , 1948, Abstracts. International Congress on Tropical Medicine and Malaria.